Open and endoscopic carpal-tunnel releases are commonly used as the definitive treatment for carpal tunnel syndrome. This ...

Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, today announced it secured more than $16 ...

Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

City councilwoman Amanda Sawyer, who opposed the bill, said a needle exchange in her district has been a ‘terrible neighbor.’ ...

Supply chain issues are top of mind at medtech companies since President-elect Donald Trump threatened tariffs on goods from ...